Sweden
· Delayed Price · Currency is SEK BINV Statistics
Total Valuation
BioInvent International AB has a market cap or net worth of SEK 2.37 billion. The enterprise value is 1.32 billion.
| Market Cap | 2.37B |
| Enterprise Value | 1.32B |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BioInvent International AB has 65.80 million shares outstanding.
| Shares Outstanding | 65.80M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 24.22% |
| Float | 32.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 44.96 |
| PB Ratio | 2.15 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.45 |
| EV / Sales | 25.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.52 |
Financial Position
The company has a current ratio of 12.30, with a Debt / Equity ratio of 1.74.
| Current Ratio | 12.30 |
| Quick Ratio | 12.18 |
| Debt / Equity | 1.74 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -675.39 |
Financial Efficiency
Return on equity (ROE) is -29.80% and return on invested capital (ROIC) is -20.59%.
| Return on Equity (ROE) | -29.80% |
| Return on Assets (ROA) | -19.25% |
| Return on Capital (ROIC) | -20.59% |
| Revenue Per Employee | 483,202 |
| Profits Per Employee | -3.52M |
| Employee Count | 111 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +117.62% in the last 52 weeks. The beta is 0.39, so BioInvent International AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +117.62% |
| 50-Day Moving Average | 38.54 |
| 200-Day Moving Average | 25.12 |
| Relative Strength Index (RSI) | 38.77 |
| Average Volume (20 Days) | 76,611 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioInvent International AB had revenue of SEK 52.67 million and -383.48 million in losses. Loss per share was -5.82.
| Revenue | 52.67M |
| Gross Profit | 52.67M |
| Operating Income | -430.90M |
| Pretax Income | -383.22M |
| Net Income | -383.48M |
| EBITDA | -420.01M |
| EBIT | -430.90M |
| Loss Per Share | -5.82 |
Balance Sheet
The company has 1.06 billion in cash and 19.11 million in debt, giving a net cash position of 1.04 billion or 15.84 per share.
| Cash & Cash Equivalents | 1.06B |
| Total Debt | 19.11M |
| Net Cash | 1.04B |
| Net Cash Per Share | 15.84 |
| Equity (Book Value) | 1.10B |
| Book Value Per Share | 16.71 |
| Working Capital | 1.03B |
Cash Flow
In the last 12 months, operating cash flow was -363.74 million and capital expenditures -12.71 million, giving a free cash flow of -376.45 million.
| Operating Cash Flow | -363.74M |
| Capital Expenditures | -12.71M |
| Free Cash Flow | -376.45M |
| FCF Per Share | -5.72 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -818.13% |
| Pretax Margin | -727.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -714.75% |
Dividends & Yields
BioInvent International AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -16.19% |
| FCF Yield | -15.91% |
Stock Splits
The last stock split was on December 14, 2020. It was a reverse split with a ratio of 0.04.
| Last Split Date | Dec 14, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.04 |